
Brainsway: Still Undervalued
Brainsway (NASDAQ:BWAY) is a provider of transcranial magnetic stimulation devices which are FDA cleared to treat Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD) and aid smoking cessation. Brainsway’s business has been significantly …